Expertise in
14
conditions

Dr. Thomas Carter

Hematology | Oncology
University Of Iowa Stead Family Children's Hospital
200 Hawkins Dr, 
Iowa City, IA 
Expertise in
14
conditions
University Of Iowa Stead Family Children's Hospital
200 Hawkins Dr, 
Iowa City, IA 

Overview

Thomas Carter is a Hematologist and an Oncologist in Iowa City, Iowa. Dr. Carter is highly rated in 14 conditions, according to our data. His top areas of expertise are Acute Monoblastic Leukemia (AmoL), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloblastic Leukemia without Maturation.

His clinical research consists of co-authoring 19 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in IA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO

Locations

University of Iowa Stead Family Children's Hospital
200 Hawkins Dr, Iowa City, IA 52242

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
Enrollment Status: Suspended
Publish Date: April 07, 2026
Intervention Type: Biological, Drug, Procedure, Other
Study Drugs: Allopurinol, Cytarabine, Daunorubicin Hydrochloride, Vincristine Sulfate, Dexamethasone, Pegylated L-Asparaginase, Methotrexate, Cyclophosphamide, Mercaptopurine, Rituximab, Doxorubicin, Thioguanine, Inotuzumab
Study Phase: Phase 3
An Open Label, Multicenter, Phase II Trial Testing Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
An Open Label, Multicenter, Phase II Trial Testing Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
Enrollment Status: Terminated
Publish Date: June 02, 2022
Intervention Type: Procedure, Drug
Study Drug: Decitabine
Study Phase: Phase 2
An Open-label, Multi-center, Expanded Treatment Protocol of Midostaurin (PKC412) in Adult Patients With Newly Diagnosed Fms-like Tyrosine Kinase Receptor (FLT3) Mutated Acute Myeloid Leukemia (AML) Who Are Eligible for Standard Induction and Consolidation Chemotherapy.
An Open-label, Multi-center, Expanded Treatment Protocol of Midostaurin (PKC412) in Adult Patients With Newly Diagnosed Fms-like Tyrosine Kinase Receptor (FLT3) Mutated Acute Myeloid Leukemia (AML) Who Are Eligible for Standard Induction and Consolidation Chemotherapy.
Enrollment Status: No_longer_available
Publish Date: July 15, 2020
Intervention Type: Drug
View 2 Less Clinical Trials

19 Total Publications

Point-of-Care Ultrasound Diagnosis of Right Ventricular Rupture Post Cardiac Arrest After Thrombolysis in Myocardial Infarction.
Point-of-Care Ultrasound Diagnosis of Right Ventricular Rupture Post Cardiac Arrest After Thrombolysis in Myocardial Infarction.
Journal: Clinical practice and cases in emergency medicine
Published: August 19, 2018
Similar Doctors
Expertise in
6
conditions
Dr. Guido Tricot
Hematology | Oncology
Expertise in
6
conditions
Dr. Guido Tricot
Hematology | Oncology

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
 (0.1 miles away)
319-356-2148
Languages Spoken:
English
See accepted insurances

Guido Tricot is a Hematologist and an Oncologist in Iowa City, Iowa. Dr. Tricot is highly rated in 6 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, Schnitzler Syndrome, and Bone Marrow Transplant.

Expertise in
52
conditions
Dr. Mohammed Milhem
Hematology
Expertise in
52
conditions
Dr. Mohammed Milhem
Hematology

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
 (0.1 miles away)
319-356-2324
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mohammed Milhem is a Hematologist in Iowa City, Iowa. Dr. Milhem is highly rated in 52 conditions, according to our data. His top areas of expertise are Melanoma, Adult Soft Tissue Sarcoma, Alveolar Soft Part Sarcoma, and Fibrosarcoma.

Expertise in
15
conditions
Dr. Yousef Zakharia
Oncology
Expertise in
15
conditions
Dr. Yousef Zakharia
Oncology

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
 (0.1 miles away)
319-356-1616
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Yousef Zakharia is an Oncologist in Iowa City, Iowa. Dr. Zakharia is highly rated in 15 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Bladder Cancer, Melanoma, and Orchiectomy.

Frequently Asked Questions about Dr. Thomas Carter

How do I make an appointment with Dr. Thomas Carter?

You can book an appointment with Dr. Thomas Carter by calling their office at 319-356-0489. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Thomas Carter a top-rated expert for Acute Monoblastic Leukemia (AmoL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Thomas Carter is classified as an Distinguished expert for Acute Monoblastic Leukemia (AmoL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Thomas Carter specialize in?

While Dr. Thomas Carter is a Hematology, they have specific expertise in Acute Monoblastic Leukemia (AmoL), Acute Myeloid Leukemia (AML), and Chronic Myelomonocytic Leukemia (CMML). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Thomas Carter participate in research or clinical trials?

Yes. Dr. Thomas Carter has published 19 articles and abstracts on conditions like Acute Monoblastic Leukemia (AmoL). You can view a list of Dr. Thomas Carter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Thomas Carter accept my insurance?

Dr. Thomas Carter accepts most major insurance plans, including Blue Cross Blue Shield. We recommend calling the office directly at 319-356-0489 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Carter's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 16 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile